Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk

Breastfeeding Medicine

Volumn 8, Issue 3, 2013, Pages 327-329

  Müller, Matthias J ^a   Preuß, Christoph ^a   Paul, Thomas ^a   Streit, Frank ^a   Brandhorst, Gunnar ^a   Seeliger, Stephan ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NORSERTRALINE; SERTRALINE;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HUMAN; INFANT; MALE; PREMATURITY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; WITHDRAWAL SYNDROME;

ADULT; ANTIDEPRESSIVE AGENTS; BLOOD-BRAIN BARRIER; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MILK, HUMAN; MOTHERS; PREGNANCY; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREMOR;

EID: 84878287442     PISSN: 15568253     EISSN: 15568342     Source Type: Journal    
DOI: 10.1089/bfm.2012.0084     Document Type: Article

References (13)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289: 3095-3105.
2. Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002;63(Suppl 7):9-15.
3. Sie SD, Wennink JM, van Driel JJ, et al. Maternal use of SSRIs, SNRIs and NaSSAs: Practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed 2012;97:F472-F476.
4. Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009;42:95-100.
5. Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011. Pharmacopsychiatry 2011;44:195-235.
6. Reis M, Aamo T, Spigset O, et al. Serum concentrations of antidepressant drugs in a naturalistic setting: Compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 2009;31:42-56.
7. Jain DS, Sanyal M, Subbaiah G, et al. Rapid and sensitive method for the determination of sertraline in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci 2005;829:69-74.
8. Levinson-Castiel R, Merlob P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006;160:173-176.
9. Lanza di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 2009;52: 483-497.
10. Stowe ZN, Hostetter AL, Owens MJ, et al. The pharmacokinetics of sertraline excretion into human breast milk: Determinants of infant serum concentrations. J Clin Psychiatry 2003;64:73-80.
11. Pilgrim JL, Gerostamoulos D, Drummer OH. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol 2011; 7:162-184.
12. Wang JS, Zhu HJ, Gibson BB, et al. Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein. Biol Pharm Bull 2008;31:231-234.
13. Petropoulos S, Gibb W, Matthews SG. Developmental expression of multidrug resistance phosphoglycoprotein (Pgp) in the mouse fetal brain and glucocorticoid regulation. Brain Res 2010;1357:9-18.